The large-scale study is designed to advance personalized medicine for pancreatic cancer to help meet the organization's goal of doubling patient survival rates by 2020.
The funding supports development of biochemistry and microfluidics for digital droplet multiple displacement amplification.
The partners will collaborate on pilot studies evaluating the Avatar system and analytics platform in the immunoprofiling of cancer patients.
The gut microbiome appears to have a role in infants' later risk of developing allergies and asthma, a new study says.
The partners will work together to see whether cell-free DNA levels can be used to predict organ injury in kidney transplantation and improve clinical outcomes.
The California Initiative to Advance Precision Medicine, which is hosted by UCSF, aims to support up to six new projects.
The researchers examined nine atrial fibrillation-linked SNPs in more than 16,500 people.
The programmable nuclease can replace restriction enzymes, enables cloning of large genomic sequences, and can deplete unwanted DNA species.
The hybrid approach expands on one described last year by Mount Sinai researchers, and relies on short-read sequencing, linked-read sequencing, and genome mapping.
The Weills are donating $185 million to the University of California, San Francisco, according to the New York Times.
A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.